Market Research Report
Central Nervous System (CNS) Biomarker Market 2021-2027
|Central Nervous System (CNS) Biomarker Market 2021-2027|
Published: August 19, 2021
Orion Market Research Pvt Ltd
Delivery time: 2-3 business days
Global Central Nervous System (CNS) Biomarker Market Size, Share &Trends Analysis Report By Application (Drug Discovery &Development, Personalized Medicine, Disease Risk Assessment, and Other), By Type (Safety Biomarker, Efficacy Biomarker, Predictive Biomarker, Prognostic Biomarker, and Validation Biomarker), and By End-User (Diagnostic Labs, Hospitals &Clinics, and, Research Centers) Forecast Period 2021-2027
The global CNS biomarker market is anticipated to grow at a significant CAGR of 15.5% during the forecast period (2021-2027). The central nervous system biomarkers market is predicted to rise due to an increase in pipeline research for the creation of biomarkers in various illness situations. As per the reports published by the American Cancer Society, in 2019, Biomarkers in Central Nervous System Tumors, specific diagnostic, prognostic, and predictive biomarkers have been discovered, and more are on the way. As a result, understanding specific biomarkers is critical for tailored treatment and follow-up.
The global CNS biomarker market is segmented based on application, type, and end-user. By application, the market is segmented into drug discovery &development, personalized medicine, disease risk assessment, and others. Further, based on the type segment, the market is segmented into safety biomarker, efficacy biomarker, predictive biomarker, prognostic biomarker, and validation biomarker. Moreover, based on the end-user segment, the market is segmented into diagnostic labs, hospitals and clinics, and research centers. Among the application segment, the personalized segment is anticipated to provide a lucrative growth opportunity to the market. The primary factor attributable to the segmental growth of the market is the rising cases of the nervous system and brain cancers, among others. Personalized medicine has widely been used as a diagnostic tool, that aids in recognizing the precised biomarker. For instance, in June 2020, Merck KGaA collaborated with Personalis, to develop biomarkers for offering cancer therapies. Additionally, through this partnership, Merck utilizes a cancer immunogenomics platform manufactured by Personalis.
Based on the regions, the CNS biomarker market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Among the regions, the CNS biomarker market is estimated to experience the largest growth in the North America region. The major factors attributable to the growth of the regional growth include the growing incidence of chronic diseases in the countries such as the US and Canada. According to the report released by GLOBOCAN, in 2020, there were around 2,281,658 new cancer cases and 612,390 deaths have been reported, due to cancer in the US. The rising development of genomics and imaging systems will further drive the growth of the market.
Further, Eli Lilly and Company, Otsuka America Pharmaceutical Inc., Aposense, Banyan Biomarkers, Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Fujirebio, Bio-Rad Laboratories, Inc., Pfizer Inc., Avacta Group PLC, and AppliedNeurosolutions, Inc., among others are some of the prominent players functioning in the global CNS Biomarker market. New product launches &developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market. For instance, in May 2020, Accure Therapeutics launched operations by initiating a series A funding worth $8.1 million. The funding has been led by Alta Life Sciences along with the Centre for Technological and Industrial Development (CDTI). Through these funding rounds, the company will manufacture new drugs for curing CNS diseases.
The market study of the global CNS biomarker market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include
Financial reports of companies involved in the market
Whitepapers, research-papers, and news blogs
Company websites and their product catalog
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Global CNS Biomarker Market Research and Analysis By Application
Global CNS Biomarker Market Research and Analysis By Type
Global CNS Biomarker Market Research and Analysis By End-User
The Report Covers
Comprehensive research methodology of the global CNS biomarker
This report also includes a detailed and extensive market overview with key analyst insights
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations
Analysis of regional regulations and other government policies impacting the global CNS biomarker market
Insights about market determinants which are stimulating the global CNS biomarker market
Detailed and extensive market segments with regional distribution of forecast revenues
Extensive profiles and recent developments of the market players.